Search research articles
Contact Us
Filters
Showing results (111-120 of 361) with videos related to
Page
of 37
Sort By:
Gastroenterology
|
September 24, 2018
Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome
Suzanne P MacFarland, Kristin Zelley, Jessica M Long, et al.
JAMA Network Open
|
August 5, 2025
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion
Mattia A Mahmoud, Sarah Ehsan, Sara P Ginzberg, et al.
JCO Precision Oncology
|
July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
The New England Journal of Medicine
|
June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Cancer Research
|
August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del
Arcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.
JCO Oncology Practice
|
July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma
Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Journal of Genetic Counseling
|
October 10, 2025
Assessment of barriers to pancreatic cancer surveillance in high-risk individuals
Grace G Snyder, Daniel Clay, Sara Karley, et al.
The American Journal of Gastroenterology
|
September 24, 2020
Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome
Bryson W Katona, Jacquelyn Powers, Danielle B McKenna, et al.
JCO Precision Oncology
|
September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic Sequencing
Dana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Page
of 37
Search research articles
Search
Showing results (111-120 of 361) with videos related to
Sort By:
Page
of 37
Gastroenterology
|
September 24, 2018
Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome
Suzanne P MacFarland, Kristin Zelley, Jessica M Long, et al.
JAMA Network Open
|
August 5, 2025
Racial Differences in Screening Eligibility by Breast Density After State-Level Insurance Expansion
Mattia A Mahmoud, Sarah Ehsan, Sara P Ginzberg, et al.
JCO Precision Oncology
|
July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
The New England Journal of Medicine
|
June 6, 2017
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson, Seock-Ah Im, Elżbieta Senkus, et al.
Cancer Research
|
August 27, 2009
Multimodal assessment of protein functional deficiency supports pathogenicity of BRCA1 p.V1688del
Arcangela De Nicolo, Emilio Parisini, Quan Zhong, et al.
JCO Oncology Practice
|
July 18, 2024
Integration of Germline Genetic Testing Into Routine Clinical Practice for Patients With Pancreatic Adenocarcinoma
Kelsey S Lau-Min, Heather Symecko, Kelsey Spielman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2016
Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing
Judith Balmaña, Laura Digiovanni, Pragna Gaddam, et al.
Journal of Genetic Counseling
|
October 10, 2025
Assessment of barriers to pancreatic cancer surveillance in high-risk individuals
Grace G Snyder, Daniel Clay, Sara Karley, et al.
The American Journal of Gastroenterology
|
September 24, 2020
Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome
Bryson W Katona, Jacquelyn Powers, Danielle B McKenna, et al.
JCO Precision Oncology
|
September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic Sequencing
Dana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Page
of 37